Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.
Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Denbow R, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Winer EP, Krop IE, Wolff AC, Wahl RL, Perez EA, Huang CY, Stearns V, Thompson EA, Connolly RM. Hennessy MA, et al. Among authors: cimino mathews a. JCO Precis Oncol. 2025 Apr;9:e2400546. doi: 10.1200/PO-24-00546. Epub 2025 Apr 3. JCO Precis Oncol. 2025. PMID: 40179327
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026).
Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Vaklavas C, Krop I, Winer E, Denbow R, Valero V, Wolff AC, Wahl RL, Huang CY, Stearns V, Thompson EA, Connolly RM. Hennessy MA, et al. Among authors: cimino mathews a. Breast. 2025 Jun;81:104432. doi: 10.1016/j.breast.2025.104432. Epub 2025 Mar 1. Breast. 2025. PMID: 40049115 Free PMC article.
A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer.
Gaillard S, Verma N, Berg M, Harrison J, Huang P, Leatherman JM, Doucet M, Sen R, Suru A, Cai H, Durham J, Jelovac D, Cimino-Mathews A, Cherry C, Ganguly S, Emens LA. Gaillard S, et al. Among authors: cimino mathews a. Gynecol Oncol. 2025 Mar;194:41-47. doi: 10.1016/j.ygyno.2025.01.015. Epub 2025 Feb 13. Gynecol Oncol. 2025. PMID: 39951918 Clinical Trial.
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ.
Debeljak M, Cho S, Downs BM, Considine M, Avin-McKelvey B, Wang Y, Perez PN, Grizzle WE, Hoadley KA, Lynch CF, Hernandez BY, van Diest PJ, Cozen W, Hamilton AS, Hawes D, Gabrielson E, Cimino-Mathews A, Florea LD, Cope L, Umbricht CB. Debeljak M, et al. Among authors: cimino mathews a. Breast Cancer Res. 2024 Dec 4;26(1):178. doi: 10.1186/s13058-024-01927-1. Breast Cancer Res. 2024. PMID: 39633428 Free PMC article.
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung Cancer.
Deutsch JS, Wang D, Chen KY, Cimino-Mathews A, Thompson ED, Jedrych J, Anders RA, Gabrielson E, Illei PB, Uttam S, Fiorante A, Cohen E, Fotheringham M, Engle LL, Sunshine JC, Wang H, Pandya D, Baxi V, Fiore J, Sidik K, Pratt J, Baras AS, Cottrell TR, Taube JM. Deutsch JS, et al. Among authors: cimino mathews a. Lab Invest. 2025 Jan;105(1):102166. doi: 10.1016/j.labinv.2024.102166. Epub 2024 Oct 24. Lab Invest. 2025. PMID: 39461426
128 results